Lexeo Therapeutics, Inc. · NASDAQ:LXEO
BlackRock, Inc.'s stake in Lexeo Therapeutics, Inc. fell to 4.00% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Oct 17, 2025
BlackRock, Inc.'s stake in Lexeo Therapeutics, Inc. fell to 4.00%, 2,168,444 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).
- Stake
- 4.00%
- Shares
- 2,168,444
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.00% | 2,168,444 |
Source
Related
- Lexeo Therapeutics, Inc.
- BlackRock, Inc.
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G · BlackRock, Inc. · Feb 4, 2025
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026